ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 137 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,574,000 | +74.7% | 79,300 | +50.5% | 0.18% | +620.0% |
| Q1 2016 | $1,473,000 | -95.2% | 52,700 | -93.9% | 0.02% | -94.6% |
| Q4 2015 | $30,913,000 | +8.5% | 867,117 | +0.7% | 0.46% | +19.3% |
| Q3 2015 | $28,487,000 | -18.7% | 861,420 | +3.0% | 0.39% | -21.6% |
| Q2 2015 | $35,025,000 | +531.5% | 836,322 | +266.9% | 0.50% | +451.1% |
| Q1 2014 | $5,546,000 | -79.9% | 227,936 | -79.4% | 0.09% | -83.4% |
| Q4 2013 | $27,655,000 | -19.3% | 1,106,622 | -11.3% | 0.54% | -30.1% |
| Q3 2013 | $34,261,000 | -6.9% | 1,247,209 | -38.5% | 0.78% | -9.7% |
| Q2 2013 | $36,805,000 | – | 2,027,787 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |